Crescent Biopharma (CBIO) Cash & Equivalents Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | 42.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.77% |
| Dec 31, 2025 | 64.53% |
| Sep 30, 2025 | 37.20% |
| Mar 31, 2025 | -33.57% |
| Dec 31, 2024 | -27.24% |
| Sep 30, 2024 | -47.92% |
| Jun 30, 2024 | -42.67% |
| Mar 31, 2024 | -38.19% |
| Dec 31, 2023 | -32.69% |
| Sep 30, 2023 | -29.81% |
| Mar 31, 2023 | -25.12% |
| Dec 31, 2022 | -32.86% |
| Sep 30, 2022 | -32.91% |
| Jun 30, 2022 | -31.11% |
| Mar 31, 2022 | -26.86% |
| Dec 31, 2021 | -24.52% |
| Sep 30, 2021 | -22.60% |
| Jun 30, 2021 | -19.69% |
| Mar 31, 2021 | -18.27% |
| Dec 31, 2020 | 3.41% |
| Sep 30, 2020 | 8.17% |
| Mar 31, 2020 | 64.80% |
| Dec 31, 2019 | 58.09% |
| Sep 30, 2019 | 55.69% |
| Jun 30, 2019 | 51.38% |
| Mar 31, 2019 | 71.41% |
| Dec 31, 2018 | 64.91% |
| Sep 30, 2018 | 59.91% |
| Jun 30, 2018 | 78.66% |
| Mar 31, 2018 | 73.36% |
| Dec 31, 2017 | 30.94% |
| Sep 30, 2017 | 22.53% |
| Jun 30, 2017 | 21.63% |
| Mar 31, 2017 | -15.32% |
| Dec 31, 2016 | 158.78% |
| Sep 30, 2016 | 80.58% |
| Jun 30, 2016 | 70.14% |
| Mar 31, 2016 | 42.25% |